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Host-cell regulation through adenovirus type 5 <p>The effects of the adenovirus Ad5 on basic host cell programs, such as cell-cycle regulation, were studied in a microarray analysis of  human fibroblasts. About 2,000 genes were up- or down-regulated after Ad5 infection and Ad5 infection was shown to induce reversal of  the quiescence program and recapitulation of the core serum response.</p>
Abstract
Background: Human adenoviruses, such as serotype 5 (Ad5), encode several proteins that can
perturb cellular mechanisms that regulate cell cycle progression and apoptosis, as well as those that
mediate mRNA production and translation. However, a global view of the effects of Ad5 infection
on such programs in normal human cells is not available, despite widespread efforts to develop
adenoviruses for therapeutic applications.
Results: We used two-color hybridization and oligonucleotide microarrays to monitor changes in
cellular RNA concentrations as a function of time after Ad5 infection of quiescent, normal human
fibroblasts. We observed that the expression of some 2,000 genes, about 10% of those examined,
increased or decreased by a factor of two or greater following Ad5 infection, but were not altered
in mock-infected cells. Consensus k-means clustering established that the temporal patterns of
these changes were unexpectedly complex. Gene Ontology terms associated with cell proliferation
were significantly over-represented in several clusters. The results of comparative analyses
demonstrate that Ad5 infection induces reversal of the quiescence program and recapitulation of
the core serum response, and that only a small subset of the observed changes in cellular gene
expression can be ascribed to well characterized functions of the viral E1A and E1B proteins.
Conclusion: These findings establish that the impact of adenovirus infection on host cell programs
is far greater than appreciated hitherto. Furthermore, they provide a new framework for
investigating the molecular functions of viral early proteins and information relevant to the design
of conditionally replicating adenoviral vectors.
Background
The Adenoviridae are nonenveloped viruses of mammals and
birds that are characterized by linear, double-stranded DNA
genomes of 34 to 43 kilobases (kb) and strikingly icosahedral
capsids that carry projecting fibers at each of the 12 vertices.
Since the first adenovirus was isolated from human adenoid
tissue in 1953, some 50 human serotypes have been identified
and associated with various syndromes, including upper
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respiratory tract infections in young children, acute respira-
tory disease in military recruits, epidemic keratoconjunctivi-
tis, and gastroenteritis. However, it was the demonstration
that some human adenoviruses induce tumors in laboratory
animals [1] that greatly increased interest in these viruses and
their interactions with host cells. Although human adenovi-
ruses can be classified as highly oncogenic, weakly oncogenic,
or non-oncogenic in rodents, all transform rodent cells in cul-
ture [2].
The viral E1A and E1B early genes are necessary and sufficient
for transformation, and E1A can also transform normal cells
in cooperation with other oncogenes, such as activated RAS
[2]. Investigation into the mechanisms by which the E1A and
E1B gene products transform cells has yielded important
insights into the cellular pathways that control cell cycle pro-
gression and programmed cell death, in particular the roles of
the tumor suppressor proteins Rb (retinoblastoma protein)
and p53 [3-7]. In addition, studies of the viral replication
cycle in permissive cells have made major contributions to
elucidating fundamental cellular processes, most famously
with the discovery of pre-mRNA splicing [8,9].
The infectious cycle of subgroup C human adenovirus, such as
adenovirus type 5 (Ad5), in permissive cells in culture is char-
acterized by a strict temporal program of viral gene expres-
sion that culminates in production of large quantities of viral
DNA and structural proteins. Viral protein encoding genes
are transcribed by the RNA polymerase II transcriptional
apparatus of the host, but viral proteins or processes orches-
trate the strict temporal sequence in which viral genes are
expressed [2]. The first to be transcribed following entry of
DNA genomes into host cell nuclei is the E1A immediate early
gene. The two most abundant E1A proteins, which are pro-
duced by translation of alternatively spliced mRNAs, differ
only in the presence in the larger of an internal sequence of 43
amino acids. This segment is one of four E1A protein
sequences that are conserved among primate adenoviruses,
and denoted conserved region (CR)1 to CR4 [10-12]. It (CR3)
is essential for efficient progression beyond the immediate
phase of the infectious cycle because it mediates activation of
transcription from viral early promoters by the larger E1A
protein [13-17]. Such stimulation appears to result from the
interaction of CR3 with a subunit of the mediator [18-21], a
multiprotein complex that can act as a co-activator or co-
repressor of transcription by RNA polymerase II [22,23].
CR2, which is common to both E1A proteins, probably con-
tributes to activation of transcription of the viral E2 early
(E2E) gene. The E2E promoter contains two binding sites for
sequence-specific transcriptional activators of the E2F family
[24]. The transcriptional functions of E2Fs are regulated by
binding of the Rb protein, which represses E2F-dependent
transcription [3-5,25]. A conserved motif within CR2 of E1A
proteins binds to the same sequence of the Rb proteins as do
E2Fs, and therefore can liberate E2Fs from inhibitory inter-
actions with Rb family members. This interaction of E1A pro-
teins with Rb is necessary for the mitogenic activity of the
viral proteins in primary cells, and for their ability to trans-
form nonpermissive cells in conjunction with the viral E1B
gene or an activated RAS oncogene [26-31].
Transcription of viral early genes leads to synthesis of some 17
early proteins, many of which perturb host cell (or host) phys-
iology. For example, several E3 proteins block host immune
responses [32,33]. The two E1B proteins can protect infected
cells against apoptosis. The E1B 19 kDa protein is a homolog
of the cellular antiapoptotic protein Bcl, which inhibits the
proapoptotic Bax [3,4,34]. In contrast, the E1B 55 kDa pro-
tein counters the consequences of activation of the tumor
suppressor p53. Binding of this E1B protein to p53 converts
the cellular protein from an activator to a repressor of tran-
scription [35,36] and, in conjunction with the viral E4 orf6
protein, the E1B protein induces accelerated degradation of
p53 [37-39]. Once the viral E2 replication proteins have
attained sufficient concentrations, viral DNA synthesis com-
mences. This event marks the transition to the late phase of
infection and is necessary for activation of the late transcrip-
tional program. Viral DNA synthesis dependent titration of a
cellular repressor permits transcription from the promoter of
the late IVa2 gene [40,41], which encodes a sequence-specific
DNA-binding protein that has been implicated in stimulation
of transcription from the major late (ML) promoter [42,43].
Transcription from the ML promoter, in conjunction with
alternative processing of ML pre-mRNAs, leads to production
of some 15 mRNAs, most of which encode viral structural pro-
teins [2].
As noted above, investigation into interactions among adeno-
viral and cellular components has greatly improved our
understanding of several fundamental processes and the
impact of viral gene products on multiple cellular pathways.
It has also set the stage for current efforts to develop adenovi-
rus vectors for therapeutic applications. Much effort has been
devoted to the design of vectors for delivery of endogenous
genes. Within this context a major goal is to minimize host
immune responses to the vector, for example by preventing
expression of viral genes and viral replication [44-47]. In con-
trast, the development of conditionally replicating adenovi-
ruses for selective killing of tumor cells depends on efficient
replication in transformed but not in normal cells [48-50].
Nevertheless, replication of the virus in normal human cells
has received little attention, despite hints of significant differ-
ences when Ad5 infects normal as compared to transformed
cells. For example, the 243R protein is dispensable for Ad5
replication in transformed HeLa cells, but it is required for
maximal replication in normal lung fibroblasts [30]. Simi-
larly, the E1B 55 kDa protein is necessary for efficient viral
DNA synthesis in Ad5 infected primary human fibroblasts but
not in established lines of human cells [51]. Although inform-
ative, such studies of individual viral gene products cannot
determine the degree to which interactions of Ad5 with hosthttp://genomebiology.com/2007/8/4/R58 Genome Biology 2007,     Volume 8, Issue 4, Article R58       Miller et al. R58.3
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Genome Biology 2007, 8:R58
cell systems differ in established and normal cells. As a first
step to address this important issue, we have undertaken a
global analysis of the changes in cellular gene expression that
accompany progression through the viral infectious cycle in
normal human fibroblasts.
Results and discussion
Kinetics of the Ad5 infectious cycle
To provide a temporal framework within which to interpret
changes in cellular gene expression induced by Ad5 infection
of normal human fibroblasts, we first examined the accumu-
lation of viral DNA, as well as of early and late viral proteins,
as a function of time of infection. The results of preliminary
experiments were used to design a time series that covered
the entire infectious cycle, while focusing on the period (18 to
42 hours after infection) in which synthesis of viral macro-
molecules and changes in viral gene expression were
maximal.
Infected cells were harvested in parallel with those from
which cellular RNA was isolated, and total DNA or protein
extracts prepared from them as described in Materials and
methods (below). The results of immunoblotting indicated
that the viral early E2 single-stranded DNA-binding protein
was present at a low concentration at 18 hours after infection,
and at a substantially higher concentration by 24 hours (Fig-
ure 1a). In contrast, the late structural protein, protein V, was
not clearly detected until 30 hours after infection, whereas
the first increase in the intracellular concentration of viral
DNA was observed between 26 and 28 hours after infection
(Figure 1a,b). These data establish that in Ad5 infected, con-
tact inhibited human foreskin fibroblasts (HFFs), the early
and late phases of infection begin at around 18 hours and
between 26 and 28 hours after infection, respectively. A sim-
ilar time course of synthesis of other viral early and late pro-
teins was observed when HFFs infected under the same
conditions were examined by immunofluorescence (data not
shown). These experiments also indicated that the viral
immediate early E1A proteins, which are required for efficient
transcription from all early promoters, such as that of the E2
transcription unit (see Background, above), were first made
between 12 and 16 hours after infection. The onset of the syn-
thesis of viral macromolecules is considerably delayed under
these conditions as compared with the infectious cycle in
established lines of human cells, such as HeLa cells, but it is
very similar to that observed previously in subconfluent, pro-
liferating HFFs [51].
Overview of alterations in cellular gene expression 
induced by Ad5 infection
We conducted two-color hybridizations using Agilent 44k
Whole Genome microarrays to examine time-dependent
changes in the concentrations of cellular RNA species in
HFFs after Ad5 or mock infection. Infected cells were har-
vested after various periods of infection, as described above,
whereas duplicate samples of mock infected cells were col-
lected at 24 and 48 hours. Zero time point samples for each
time course (two zeros for the mock and three for the Ad5
infection) were collected immediately after the 1 hour adsorp-
tion period. Labeled cRNAs prepared from Ad5 or mock
infected samples (red channel) were hybridized competitively
with approximately equal concentrations of a common refer-
ence cRNA (green channel). The reference cRNA was made
from a mixture of RNAs originating from a diverse set of
human cells and cell lines. These differed in terms of history
(primary and transformed) and proliferation state (over-
grown, cycling, and quiescent), and were chosen in order to
maximize the diversity of detectable cellular transcripts, by
minimizing the number of probes on the arrays with below-
background signals in the reference channel.
For each hybridization, variations in the input of labeled
cRNA were corrected by a standard computational dye nor-
malization (see Materials and methods, below). To facilitate
comparison of the response profiles of individual probes with
each other and with the temporal origin of the experiment, we
zero transformed the data by probe; the log2 expression val-
ues of each probe in the mock and Ad5 time courses were lin-
early transformed by subtracting the mean values of the
corresponding zero samples. Finally, to isolate a core set of
probes that exhibited significant changes in expression spe-
cifically in response to Ad5 infection, we applied the following
intensity filters; probes were required to exhibit a log2 expres-
sion value ≥ 1 (equivalent to 2-fold change) at at least three
time points in the Ad5-infected series, and a log2 expression
value ≤ 0.4 (equivalent to 1.3-fold change) in no more than
two arrays in the mock infected series.
Application of these criteria identified 2,104 genes (unique
Unigene clusters), of the 20,590 on the arrays, whose expres-
sion exhibited a sustained change of twofold or greater fol-
lowing Ad5 infection, but were not significantly altered in
mock infected cells. (For a complete list of genes that pass
these filters, see Additional data file 1. The complete unfil-
tered dataset can be accessed at the Princeton University
Microarray database [PUMA] [52].)
As a comparison with our simple filter for differential expres-
sion, we applied significance analysis of microarrays (SAM)
[53]. Specifically, we looked for genes that were significantly
differentially regulated at two different times after infection,
a s  c o m p a r e d  w i t h  t h e  t r i p l i c a t e  z e r o  t i m e  p o i n t  m e a s u r e -
ments. To overcome the absence of replicate measurements
of Ad5 infected cells, we treated the three measurements sur-
rounding both 26 and 40 hours as triplicate measurements.
Two groups of measurements, the first taken at 24, 26, and 28
hours after infection and the second group taken at 38, 40,
and 42 hours, were tested independently for differential
expression compared with the triplicate zero time point. To
make the SAM results comparable with the results of our two-
fold filter discussed above, we excluded all genes thatR58.4 Genome Biology 2007,     Volume 8, Issue 4, Article R58       Miller et al. http://genomebiology.com/2007/8/4/R58
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exhibited any change in response to mock infection. We then
performed independent two-class unpaired analysis for the
two sets of pseudo-replicates centered at 26 and 40 hours,
and combined the results of these two tests. Using a false dis-
covery rate of no more than 0.1%, we identified 5,262 genes
that are differentially expressed at 26 or 40 hours after infec-
tion. This number far exceeds the 2,104 that pass the fold
change filters. In addition, 96% of the genes that pass the fold
change filter above were also found by the SAM analysis to
exhibit statistically significant differential expression (P < 10-
10). Thus, our fold change criteria defined a subset of statisti-
cally significantly differentially expressed genes that exhibit
the strongest changes in mRNA levels in response to Ad5
infection.
The concentrations of a subset of the cellular RNAs that
exhibited changes in response to Ad5 infections satisfying our
fold change filter were determined using an alternative
method, namely reverse transcription (RT)-polymerase chain
reaction (PCR). In parallel, we examined the same RNAs in
samples isolated at various times after two additional and
independent infections of HFFs. Representative results of the
RT-PCR experiments are shown for CDC6 RNA in Figure 2a.
Although the absolute quantities of CDC6 RNA present after
increasing periods of infection varied among infections, the
temporal patterns of changes in concentration were the same
in all cases. The gene expression patterns for 16 different
genes were determined by RT-PCR. The data were zero trans-
formed and converted to log2 values for comparison with the
microarray data (Figure 2b and Additional data file 2). The
two methods of analysis yielded closely similar patterns of
temporal changes in expression for 14 of the 16 genes exam-
ined (87.5%), as illustrated in Figure 2b for two RNAs that
differed in direction as well as magnitude of Ad5-induced
alterations. These results establish both the reproducibility of
the changes in cellular gene expression induced by Ad5 infec-
tion of quiescent HFFs and the reliability of the alterations
detected by hybridization to microarrays.
In addition to confirming our results by statistical and quan-
titative means, we wished to compare them with those of pub-
lished reports of changes in cellular gene expression induced
by adenovirus infection. During the early phase of Ad5 infec-
tion of transformed HeLa cells, expression of 76 cellular
genes of the 12,309 examined was observed to be increased or
decreased by a factor of 1.5-fold or greater, whereas
Kinetics of the Ad5 infectious cycle in quiescent HFFs Figure 1
Kinetics of the Ad5 infectious cycle in quiescent HFFs. Quiescent human foreskin fibroblasts (HFFs) were infected with 30 plaque forming units/cell 
adenovirus type 5 (Ad5) and total DNA or protein extracts prepared after various periods of infection, as described in Materials and methods. (a) 
Concentrations of viral DNA were determined by limiting polymerase chain reaction amplification of a sequence with the E1A gene. Purified Ad5 (Ad5) 
and human (Hu) DNAs were amplified as positive and negative controls, respectively. (b) The viral early E2 and late V proteins, and the cellular β-actin 
protein were examined by immunoblotting.
(a)
(b)
Hu Ad5 54 48 42 40 38 36 34 32 30 28 26 24 18 12 0 Hrs p i
54 48 42 40 38 36 34 32 30 28 26 24 18 12 0 Hrs p i
E2-ssBP
Protein V
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expression of 112 genes was specifically altered during the late
phase of infection [54,55]. The majority of these RNAs exhib-
ited similar alterations in concentration following Ad5 infec-
tion of HFFs (Figure 3). However, expression was modulated
for a significantly larger proportion of the cellular genes
examined in Ad5-infected HFFs than in HeLa cells (10.5%
versus about 1.5%).
Differences in the methods used to collect and analyze
hybridization data are likely to contribute to these seemingly
disparate responses to infection, as are the genetic histories of
the infected cells. Highly transformed and genetically abnor-
mal cells, such as HeLa cells, are likely to be less sensitive to
stresses such as viral infection, and may have lost cellular
systems that are targeted by adenovirus in normal diploid
fibroblasts. For example, HeLa cells contain integrated copies
of the human papillomavirus type 18 oncogenes encoding the
E6 and E7 proteins [56], which, like adenoviral E1B and E1A
proteins (see Background, above), inactivate the cellular
tumor suppressors p53 and Rb, respectively [57-59]. How-
ever, as discussed below, an important determinant of the
extent to which cellular gene expression is reprogrammed in
Ad5 infected cells appears to be whether cells are proliferat-
ing (subconfluent HeLa cells) or quiescent (contact-inhibited
HFFs) at the time of infection. In addition to a larger number
of responsive genes, our analysis of cellular RNA concentra-
tions at many time points has identified multiple temporal
responses to Ad5 infection.
Clustering of co-regulated genes
In order to identify groups of genes that exhibited significant
co-regulation, we chose to apply a k-means clustering algo-
rithm to the filtered dataset. The clustering process begins by
randomly assigning all genes to k total clusters and computes
a centroid vector for each cluster. The algorithm then itera-
tively reassigns genes to clusters based on the closest match
(highest Pearson correlation) of individual expression vectors
to the cluster centroids, until no changes allow better matches
of gene to cluster means. To ensure that the final clustering
result was not sensitive to the initial, random assignment of
centroids, we report the consensus of 5,000 such runs of k-
means clustering. We determined an appropriate number of
clusters, k, by using figure of merit (FOM) analysis, which
measures the predictive power of a clustering result by leav-
ing one condition out of the clustering process and measuring
how predictive the cluster centroids are of the held-out condi-
tion [60]. Details of the consensus clustering are discussed in
Materials and methods (below).
In this way, eight groups of genes were clearly distinguished
on the basis of the temporal patterns of alterations in the cor-
responding RNA concentrations induced by Ad5 infection
(Figure 4). Although approximately equal numbers of cellular
RNA species represented in the total dataset increased or
decreased in concentration during the viral infectious cycle
(data not shown), nearly two-thirds of the probe responses in
the filtered list exhibited an increase in RNA concentration.
Changes in RNA concentrations in Ad5-infected HFFs determined by RT-PCR Figure 2
Changes in RNA concentrations in Ad5-infected HFFs determined by RT-PCR. (a) Autoradiograms of products of reverse transcription (RT)-polymerase 
chain reaction (PCR) amplification of CDC6 RNA isolated from human foreskin fibroblasts (HFFs) infected for the periods indicated. The RNA samples 
used in experiment 1 were those also used for amplification and hybridization to microarrays, whereas experiments 2 and 3 total RNAs were from two 
other independent infections of quiescent HFFs. (b) The RT-PCR signals for E2F2 and RHOQ RNAs from the three independent infections were 
quantified, as described in Materials and methods, zero transformed against the mean of the three zero time point samples included in each experiment, 
and converted to log2 values for comparison to the changes in concentration of these RNAs determined by hybridization to microarrays. Ad5, adenovirus 
type 5.
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Comparison of adenovirus-induced changes in gene expression in HeLa cells and HFFs Figure 3
Comparison of adenovirus-induced changes in gene expression in HeLa cells and HFFs. The genes reported to exhibit changes in expression at (a) 6 hours 
or (b) 10 and 21 hours after infection of HeLa cells by adenovirus type 2 (Ad2) [54,55] were isolated from our dataset and clustered on the basis of their 
responses to infection of human foreskin fibroblasts (HFFs). The changes observed in HeLa cells are summarized in the columns labeled Ad2, in which 
yellow and blue represent increased and decreased expression respectively. In panel b, the HeLa response is based on the average of the two time points. 
Ramps above panels indicate increases in time after infection.
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Kinetic patterns of expression of Ad5-responsive genes and associated cellular functions Figure 4
Kinetic patterns of expression of Ad5-responsive genes and associated cellular functions. The log2 expression values of the 2,106 genes that passed the 
filters described in the text clustered into eight groups are shown at the left, and over-represented Gene Ontology (GO) terms in each cluster at the right. 
Also shown is a color-bar relating both log2 ratios and fold changes (relative to the average zero values) to color intensity. Ad5, adenovirus type 5.
Log2 ratio:   -2.5 +2.5 -1.0 +1.0
Fold:   -5.7 +5.7 -2.0 +2.0
 GO term ID      GO term description               P value Mock Adenovirus type 5
GO:0031497     Chromatin assembly                    1.19E-08
GO:0006334     Nucleosome assembly                1.99E-08
GO:0008380    RNA splicing                                9.48E-09
GO:0006260    DNA replication                            1.03E-08
GO:0007049    Cell cycle                                     2.22E-08
GO:0007067    Mitosis                                          9.76E-07
GO:0000087    M phase                                       5.71E-06
GO:0046907    Intracellular transport                   4.15E-05
GO:0006913    Nucleocytoplasmic transport        1.04E-04
GO:0006281    DNA repair                                   <1.0E-11
GO:0006260    DNA replication                            1.29E-08
GO:0007049    Cell cycle                                      1.77E-08
GO:0007046    Ribosome biogenesis                    7.86E-08
GO:0000279    M phase                                       1.54E-04
GO:0006929    Substrate-bound cell migration     5.57E-04
GO:0042254     Ribosome biogenesis                   3.55E-08
1
2
3
4
5
6
7
8
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Those exhibiting a reduction in concentration fell into three
clusters, distinguished primarily by the time after infection at
which a significant change in RNA concentration was first
detected: early after infection, 24 hours (cluster 7), or late in
infection, between 32 and 36 hours (cluster 2). A third cluster
of downregulated genes (cluster 4) consisted of a small
number of genes encoding RNAs that decreased in concentra-
tion early in infection, reached their lowest levels between 34
and 38 hours after infection, but returned to baseline concen-
trations by the end of infection (Figure 4). In contrast, the
kinetic patterns of increases in cellular RNA concentrations
were considerably more variable, in terms of both the time
after infection at which an increase was first detected and the
duration of the change (Figure 4). For example, increased
accumulation of a substantial number of cellular RNAs was
evident by 18 or 24 hours after infection, but in some cases
RNA concentrations subsequently decreased (clusters 3 and
6), whereas in others the initial alteration was sustained
(cluster 1) or amplified (cluster 5) later in the infectious cycle.
The number of RNA species observed to increase in concen-
tration during the late phase of infection was relatively small
(about 500; Figure 4). Unexpectedly, however, the maximal
increases in accumulation of these RNAs were observed very
late in the infectious cycle, from 48 hours after infection
(clusters 8), when infected cells are largely devoted to assem-
bly of virus particles.
Analysis of cellular functions targeted by Ad5 infection
In an attempt to identify cellular functions that are predomi-
nantly affected by Ad5 infection, we searched the filtered list
of genes significantly altered in expression for statistical over-
representation of functional classes. We used a local imple-
mentation of GoTermFinder (see Materials and methods,
below), which maps each gene in a query list to a node in the
'biologic process' ontology of the Gene Ontology Consortium
[61], and computes a probability for the preponderance of
each function in the query list. To avoid a possible function
bias in the population of genes present on the arrays, the P
value for over-representation was computed using all genes
on the array as the background population. In addition, the P
value was Bonferroni-corrected for multiple hypothesis test-
ing. In this way, several important cellular functions were
found to be modulated specifically in response to Ad5 infec-
tion (Table 1). We wished to determine whether the specific
targeting of cellular functions correlated with temporal pat-
terns of changes in gene expression, and therefore searched
the kinetic clusters generated by consensus k-means cluster-
ing (Figure 4) for over-represented function terms.
Several instances of Ad5-induced co-regulation of genes asso-
ciated with common cellular functions were identified (Figure
4). Cellular RNAs that increased in concentration slowly and
steadily throughout most of the observed infectious cycle,
which are grouped in cluster 5, exhibited a highly significant
enrichment in RNAs specifying proteins that participate in
the establishment and maintenance of chromatin structure (P
= 10-8). These RNAs encode chromatin modifying proteins,
such as the histone methyl transferase DotIL and subunits of
the NuAY histone acetyl transferase, and numerous core his-
tones, including the S-phase specific histone H2BFS. Cluster
1 contains RNAs that increased in abundance early in
response to Ad5 infection and remained elevated thereafter.
Genes encoding RNA splicing components are significantly
enriched in cluster 1 (P = 10-8), and these RNAs encode sev-
eral snRNP core Sm and Sm-like protein proteins, SF3A sub-
units, and proteins critical for enhancer mediated splicing.
RNAs encoding proteins that mediate nucleocytoplasmic
transport of both RNA and protein molecules, such as import-
ins and nucleoporins, were also over-represented in cluster 1
(P = 10-4).
As discussed above, cellular RNAs that exhibited strong, Ad5-
induced increases in concentration early in infection (18 to 24
hours) fell into three main kinetic clusters that differ in terms
of whether initial increases in RNA concentration were main-
tained for the duration of the viral life cycle (cluster 1) or
steadily declined from 34 hours after infection (clusters 3 and
6). Despite differences in temporal patterns of expression,
these clusters exhibited common enrichment in genes
ascribed important functions related to cellular proliferation
(Figure 4). Both clusters 1 and 3, which are distinguished by
whether initial increases in RNA concentration were sus-
tained throughout the infection, were strongly enriched in
genes specifying proteins that function in progression
through the cell cycle (P = 10-8 in both). These include check-
point proteins, DNA replication licensing proteins, and cell
cycle promoting transcription factors. Enrichment for
increased expression of such cell cycle genes is consistent
with the well established mitogenic activity of viral E1A pro-
teins (see below). Furthermore, genes encoding proteins that
mediate or regulate DNA replication were also highly
enriched in clusters 1 and 3 (P = 10-8 in both), as were genes
associated with M phase (P = 10-5 and P = 10-4, respectively).
These include genes encoding subunits of DNA polymerases,
and Mcm complex components, as well as subunits of the
anaphase promoting complex, mitotic checkpoint proteins,
and proteins that regulate spindle formation, chromosome
condensation and chromosome segregation. Interestingly,
cluster 3 is also highly enriched for transcripts of DNA repair
genes (P < 10-11). In particular, the Fanconi anemia group
pathway of DNA repair is heavily targeted by Ad5 infection, as
are the central pathways required for the detection and sign-
aling of DNA damage, represented by the catalytic subunit of
DNA-dependent protein kinase and the UV damage sensor
Rad18. Finally, cluster 6 differs from cluster 3 in that the peak
expression levels reached early after infection, subsequently
decreased far more dramatically than those in cluster 3, and
returned to near baseline levels by 60 hours. Nevertheless,
both cluster 3 and 6 are highly enriched for genes involved in
another cellular function important for growth and prolifera-
tion, namely ribosome biogenesis (P  = 10-7 and  P  = 10-8,
respectively). Nucleolar proteins feature prominently in thesehttp://genomebiology.com/2007/8/4/R58 Genome Biology 2007,     Volume 8, Issue 4, Article R58       Miller et al. R58.9
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two clusters, including many that participate in pre-rRNA
biosynthesis and maturation, as well as ribosome particle
assembly.
Assuming that changes in cellular gene expression induced by
Ad5 infection result in corresponding increases or decreases
in protein production, and hence activity, we can conclude
that the diversity of cellular functions modulated during the
adenoviral life cycle is far greater than was previously appre-
ciated. Perhaps even more striking is the substantial enrich-
ment in the 2,000 or so RNAs that changed most strongly in
concentration in Ad5-infected HFFs, with those that encode
proteins that mediate and regulate cell cycle progression and
cell proliferation (Figure 4). Because the HFFs were quiescent
at the time of infection, this finding prompted us to undertake
a comparison of alterations in gene expression induced by
infection and by entry into, and exit from, the quiescent state.
Ad5 infection induces reversal of the quiescence program and 
recapitulation of the core serum response
Upon reaching confluence in tissue culture, primary fibrob-
lasts undergo a highly regulated transition into a reversible
growth arrest termed quiescence. Recently, the core altera-
tions in gene expression that accompany this process in dip-
loid human fibroblasts were defined [62]. To determine
whether the genes associated with the induction of the quies-
cence program exhibited any systematic changes in expres-
Table 1
Cellular functions associated with genes significantly regulated by Ad5 infection
GO term ID GO term description P value
Cellular functions associated with down-regulated genes
GO:0045449 Regulation of transcription 5.97 × e-06
GO:0007154 Cell communication 1.63 × e-04
GO:0007165 Signal transduction 1.05 × e-03
GO:0007275 Development 5.42 × e-03
Cellular functions associated with up-regulated genes
GO:0006281 DNA repair < 0.00 × e-11
GO:0042254 Ribosome biogenesis and assembly < 0.00 × e-11
GO:0007046 Ribosome biogenesis 3.60 × e-09
GO:0008380 RNA splicing 4.73 × e-09
GO:0006260 DNA replication 1.71 × e-08
GO:0007049 Cell cycle 2.03 × e-08
GO:0000279 M phase 3.52 × e-08
GO:0006913 Nucleocytoplasmic transport 1.12 × e-05
GO:0006270 DNA replication initiation 4.37 × e-05
GO:0006334 Nucleosome assembly 8.81 × e-05
GO:0051169 Nuclear transport 1.86 × e-04
GO:0051301 Cell division 1.95 × e-04
GO:0031497 Chromatin assembly 7.92 × e-04
GO:0009156 Ribonucleoside monophosphate biosynthesis 4.32 × e-03
GO:0009124 Nucleoside monophosphate biosynthesis 7.06 × e-03
Ad5, adenovirus type 5; GO, Gene Ontology.
Ad5 infection induces reversal of the quiescence program Figure 5
Ad5 infection induces reversal of the quiescence program. The expression 
responses of the quiescence program genes to adenovirus type 5 (Ad5) 
infection were isolated, and divided into two groups on the basis of 
expression changes during quiescence. The members of each group 
(downregulated during quiescence and upregulated during quiescence) 
were then hierarchically clustered and the two groups then rejoined for 
visualization. The genes named at the right are discussed in the text. 
Ramps above panels indicate increases in time after infection.
NFKB2
MX2
TRIM22
STAT1
IFITM1
Down-regulated
during quiescence
Up-regulated
during quiescence
Mock Adenovirus type 5
00R58.10 Genome Biology 2007,     Volume 8, Issue 4, Article R58       Miller et al. http://genomebiology.com/2007/8/4/R58
Genome Biology 2007, 8:R58
sion after Ad5 infection, the expression changes of the genes
that are specifically upregulated or downregulated as primary
lung fibroblasts become quiescent were linked to the expres-
sion changes in response to Ad5 infection of quiescent HFFs.
The data were then organized by regulation of gene expres-
sion during quiescence (Figure 5).
Strikingly, genes encoding RNAs that decreased in concentra-
tion during quiescence were preferentially upregulated dur-
ing infection, whereas the transcripts of genes activated
during quiescence exhibited nearly systematic Ad5-induced
decreases in abundance. To test whether this opposing pat-
tern was statistically significant, we clustered the infection
responses into two groups, namely those exhibiting an
upward and those exhibiting a downward trend (data not
shown), and used the hypergeometric probability distribution
to compute P values for the nonrandom representation of qui-
escence RNAs in each cluster. Downregulated quiescence
genes were significantly enriched in the cluster of Ad5 upreg-
ulated responses, and upregulated quiescence genes in the
cluster of Ad5 downregulated RNAs (P 7 × 10-4 and 9 × 10-5,
respectively). Furthermore, the set of genes that did not con-
form to the reverse pattern (< 30% of the quiescence program
genes) generally exhibited weak responses to Ad5 infection
and were less than half as likely to pass cutoff filters com-
pared with the set of genes that did conform to the pattern of
quiescence reversal. In addition, the several genes that were
upregulated both during quiescence and late in Ad5 infection
encode proteins (myxovirus resistance protein 2, NF-kappa-
B2 [p49/p100], Trim22, and Stat1) that are components of
the host antiviral defense mediated by interferon [63,64].
In all, our findings show a robust reversal of the expression
profile recently identified as the core signature of quiescence.
The late changes in RNA concentration, and the cellular func-
tion of the corresponding genes that do not conform to this
reversal, suggest that their increased expression is part of a
general response to infection, superimposed on the Ad5-spe-
cific reversal of the quiescence program.
Prolonged serum withdrawal represents one way in which
quiescence can be induced in primary cells. Upon re-addition
of serum, the quiescent state is reversed, and cells re-enter
the cell cycle, accompanied by profound changes in their gene
expression profile. In fibroblasts, these changes clearly reflect
their role in wound healing [65]. The apparent reversal of the
quiescence gene expression program induced by Ad5
infection suggested that infection of quiescent fibroblasts by
Ad5 may represent an event akin to serum stimulation. To
test this hypothesis, we isolated the Ad5 induced changes in
expression of the core serum response (CSR) signature genes
identified by Chang and coworkers [66,67]. In remarkable
studies, those researchers showed that primary human
fibroblasts from different parts of the body exhibit distinct
location specific expression profiles [66], yet they share a
common transcriptional response to serum [67]. The latter is
termed the CSR, and is defined as the set of 512 genes that, in
all 50 fibroblast lines from 10 different anatomical sites,
exhibit differential expression when cultured in the presence
or absence of serum. Importantly, genes that had been found
to show a periodic pattern of altered expression during the
cell cycle [68] were excluded from this list. Thus, the CSR rep-
resents a stereotyped, serum dependent gene expression sig-
nature, which is independent of cell cycle associated
responses to serum.
We hierarchically clustered the genes that comprise the CSR
on the basis of their alterations in expression during Ad5
infection of HFFs (Figure 6). This approach established that
increases in expression in response to infection are highly
correlated with elevated gene expression in the presence of
serum. Similarly, Ad5 induced decreases were correlated with
lower expression in response to serum (Figure 6). Indeed, the
concordance between the two datasets for this group of genes
is remarkable (P < 10-34 and P < 10-14 for RNAs that decreased
and increased in concentration during Ad5 infection, respec-
tively). These findings strongly suggest that Ad5 infection not
only elicits a reversal in the gene expression program that is
characteristic of quiescent human fibroblasts, but also
Induction of the core serum response by Ad5 infection Figure 6
Induction of the core serum response by Ad5 infection. The responses of 
the core serum response (CSR) genes to adenovirus type 5 (Ad5) 
infection were isolated and clustered on the basis of their response to Ad5 
infection. The serum dependent expression responses are summarized in 
yellow or blue (activated or repressed, respectively) in the rightmost 
column labeled CSR. Ramps above panels indicate increases in time after 
infection.
Adenovirus type 5 Mock
CSR 00http://genomebiology.com/2007/8/4/R58 Genome Biology 2007,     Volume 8, Issue 4, Article R58       Miller et al. R58.11
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induces a nearly perfect recapitulation of the highly specific
core gene expression profile exhibited by cells that proliferate
in the presence of serum growth factors. Underscoring its
close association with the wound healing program, the CSR is
significantly enriched for genes encoding proteins that partic-
ipate in blood coagulation, complement activation, and
angiogenesis, and contains genes associated with cell motil-
ity, extracellular matrix remodeling, and the myofibroblast
phenotype [67]. Thus, in addition to the induction of
proliferation (see above), it appears that Ad5 infection
induces a cellular state closely associated with a specialized,
serum dependent fibroblast function.
In addition to providing a molecular fingerprint of fibroblasts
that grow in the presence of serum, the transcriptional CSR
phenotype has been shown to be a robust predictor of the clin-
ical outcome of several human carcinomas [67]. The metasta-
sis and death associated with these human tumors correlated
strongly with expression of the CSR phenotype. Thus, even
though adenovirus infection is not tumorigenic in humans, it
appears that infection of human cells induces a transcrip-
tional state associated with aggressive tumor progression and
poor clinical outcome.
Mechanisms by which Ad5 gene products regulate 
cellular gene expression
The E1A proteins
Internalization of adenovirus particles by receptor mediated
endocytosis is initiated by binding of the capsid penton base
to cell surface α'i integrin molecules [2]. This interaction also
results in very rapid (within 10 min), transient activation of
phosphoinositide-3-OH kinase [69]. Although activation of
signaling via this enzyme has the potential to alter gene
expression [70-73], we detected no changes in cellular RNA
concentrations during the first hours of the infectious cycle
(Figure 4). Rather, the earliest alteration detected took place
at 18 hours after infection (Figure 4), coincident with the
onset of viral early gene expression (Figure 1). These changes
in cellular gene expression are almost certainly the result of
changes in rates of transcription; post-transcriptional mech-
anisms that govern RNA production in Ad5-infected cells
operate only late in infection (see Background, above). Fur-
thermore, the adenoviral immediate early E1A proteins,
which are necessary for efficient progression beyond the ini-
tial phase of the infectious cycle, can regulate transcription by
multiple mechanisms. In view of the findings reported above,
the effects of CR2 of E1A proteins on cellular E2F proteins
were of particular interest.
The E2F transcriptional regulators were first identified, and
named, by virtue of their ability to bind specifically to two
sites in the type C adenoviral E2 early promoter [24]. This
family is now known to comprise at least eight members,
which differ in their association with Rb family members,
effects on transcription, and mechanisms of binding to DNA
[74-78]. For example, E2F-1, E2F-2, and E2F-3 bind directly
to the Rb protein and are strong activators of transcription.
They are also necessary for activation of E2F-responsive
genes and entry into S phase [79]. E2F-4 and E2F-5 can also
associate with other members of the Rb family and stimulate
transcription less strongly, whereas E2F-6, E2F-7, and E2F-8
appear to repress transcription. Association of E2F proteins
with Rb, which inhibits expression of E2F responsive genes,
is normally regulated during the cell cycle by phosphorylation
of Rb [80]. However, CR2 dependent binding of E1A to Rb
protein induces release of E2F, and hence activation of tran-
scription of E2F responsive genes and induction of progres-
sion into the S phase of the cell cycle [3,81,82]. These effects
of CR2, results discussed in the previous section, and the
observation that RNAs encoding E2F-1 and E2F-2 increased
significantly in concentration from 24 hours after Ad5 infec-
tion, whereas E2F-4, E2F-5 and E2F-7 RNAs did not, sug-
g e s t e d  t h a t  E 2 F - r e s p o n s i v e  g e n e s  w e r e  l i k e l y  t o  b e  h i g h l y
targeted in Ad5 infected HFFs.
A common method used to associate particular transcrip-
tional regulators with induction of specific patterns of gene
expression is to search the regulatory sequences of co-regu-
lated genes for statistically significant over-representation of
binding sites for such proteins. An initial, manual search of
the entire set of genes from positions -1,000 to +500 for the
two most common variants of an 8 base pair (bp) E2F consen-
sus binding site [83,84] identified a large number of potential
E2F-responsive genes (some 500). Nearly 80 of these were
genes were in clusters 1, 3, and 4, which contain genes
specifying RNAs that increased in concentration in response
to Ad5 (data not shown). However, in the case of E2F, meth-
ods based on identification of binding site sequences are
problematic; the currently defined consensus binding sites
for members of this family includes a significant degree of
degeneracy [83,84]. Furthermore, it has recently been
reported that many sequences to which E2F binds in vivo do
not match such consensus sequences [85]. We therefore
examined the effects of Ad5 infection on the expression of
genes to which E2F family proteins are known to bind in vivo,
which have been identified by immunoprecipitation of E2F
containing chromatin and microarray analysis of the DNA
[86].
From our complete, that is, unfiltered, dataset we isolated the
expression changes of the direct E2F target genes identified
by Ren and coworkers [86], while excluding genes that
exhibit changes in expression in response to mock infection.
Comparison with an equal number of randomly selected
genes from this dataset revealed strong enrichment of Ad5
responsive genes among direct E2F target genes (Figure 7). In
fact, 60% of the 67 E2F target genes that showed no signifi-
cant response in mock infected cells passed the stringent fold-
change filtering scheme applied previously (compared with
10% of all the genes in the dataset), and all but seven are
grouped in clusters 1 and 3 (Figure 4) with the genes thatR58.12 Genome Biology 2007,     Volume 8, Issue 4, Article R58       Miller et al. http://genomebiology.com/2007/8/4/R58
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exhibit the earliest activation in response to Ad5 infection
(data not shown).
We then tabulated the Ad5 specific expression responses of
the E2F target genes according to function (Figure 7). Genes
that passed the fold change filter applied previously were
labeled as responsive, either up or down. Across all functions,
a significantly higher proportion of E2F target genes showed
significant changes in the concentrations of their RNA tran-
scripts in Ad5 infected HFFs, relative to all genes in the
dataset. Moreover, the expression of all E2F target genes
increased, rather than decreased, in infected cells. It is there-
fore likely that during infection of nonproliferating cells,
effects mediated by CR2 of the E1A proteins account for an
important subset of the changes in cellular gene expression
s u m m a r i z e d  i n  F i g u r e  3 ,  a s  p r e d i c t e d  b y  c u r r e n t  m o d e l s
[3,81,82]. Unexpectedly, however, we observed that the
expression of some functional groups of genes bound by E2F
was more heavily affected than that of others (Figure 8).
Notably, E2F targets encoding proteins that mediate or regu-
late cell cycle progression and DNA replication and repair
exhibited much greater propensity to change in response to
Ad5 than did genes associated with transcription, intracellu-
lar transport, or development (Figure 8). These different
responses might be the result of preferential recognition of
E2F responsive promoters by different E2F family members
or effects of other transcriptional regulators that also recog-
nize such promoters. Regardless, such function specific, dif-
ferential regulation of E2F target genes suggests that
additional mechanisms must regulate expression of E2F
responsive genes, or E2F proteins, in adenovirus infected
cells.
The E2F responsive genes described above represent but a
subset of those that increased or decreased in expression dur-
ing the early phase of Ad5 infection. However, E1A proteins
can modulate cellular transcriptional regulators by at least
three additional mechanisms. Because the interaction of CR3
of the large E1A protein with the mediator complex (see
Background, above) both stimulates transcription by RNA
polymerase II in vitro [21] and is necessary for efficient tran-
scription of viral early genes in infected cells [20], it may well
contribute to activation of cellular gene expression. CR1 and
CR4 of the E1A proteins associate with various histone acety-
lases that activate transcription [3] and the transcriptional
co-repressor Ct-BP [87,88], respectively. The latter interac-
tion inhibits E1A dependent transformation, whereas CR1 is
necessary for transformation. Neither the transcriptional
consequences of association of CR1 or CR4 with cellular co-
activators or co-repressors, nor the contributions of these
E1A sequences to the viral infectious cycle are understood.
However, these interactions could well result in either
increases or decreases in transcription of specific cellular
genes. It will therefore be of interest to examine the effects of
substitutions that block the interactions of these conserved
regions of E1A proteins with cellular components on cellular
gene expression.
The expression of E2F target genes in Ad5 infected HFFs Figure 7
The expression of E2F target genes in Ad5 infected HFFs. (a) The 67 genes bound by E2F2 or E2F4 identified by Ren and coworkers [86] and (b) 67 
randomly chosen genes were isolated from the complete dataset while excluding genes with responses to mock treatment. The genes in both panels were 
hierarchically clustered for easier viewing. Ramps above panels indicate increases in time after infection. Ad5, adenovirus type 5; HFF, human foreskin 
fibroblast.
Ad5 Mock Ad5 Mock
0 00 0
(b) (a)http://genomebiology.com/2007/8/4/R58 Genome Biology 2007,     Volume 8, Issue 4, Article R58       Miller et al. R58.13
c
o
m
m
e
n
t
r
e
v
i
e
w
s
r
e
p
o
r
t
s
r
e
f
e
r
e
e
d
 
r
e
s
e
a
r
c
h
d
e
p
o
s
i
t
e
d
 
r
e
s
e
a
r
c
h
i
n
t
e
r
a
c
t
i
o
n
s
i
n
f
o
r
m
a
t
i
o
n
Genome Biology 2007, 8:R58
The E1B 55 kDa protein
Like E1A proteins, the E1B 55 kDa protein can also modulate
cellular gene expression by multiple mechanisms. In terms of
molecular detail, the best understood is repression of p53-
dependent transcription [35,36]. Such inhibition of the tran-
scriptional function of this cellular tumor suppressor protein
is mediated by binding of the viral protein to the activation
domain of p53 [89-91]. The results of in vitro experiments
indicate that, when associated with p53, the E1B protein
actively represses transcription [89,90]. It is therefore
believed that the carboxyl-terminal repression domain of the
E1B 55 kDa protein is recruited to specific promoters via the
DNA binding activity of p53 to repress transcription of p53
responsive genes. Consistent with this model, substitutions or
insertions at specific positions within the E1B repression
domain prevent inhibition of transcription in transient assays
or in in vitro reactions [35,89]. These mutations also impair
the ability of the E1B gene to cooperate with E1A in transfor-
mation of rodent cells. In addition, it has been reported that
the E1B 55 kDa protein inhibits acetylation of p53 by the his-
tone acetyltranferase PCAF [92], a modification that is
important for activation of p53 [93]. The viral protein also
prevents stimulation of p53 dependent transcription in tran-
sient expression assays by the cellular protein Daxx [54].
However, it is not known whether p53 dependent transcrip-
tion is repressed during Ad5 infection, as these observations
predict. We therefore wished to exploit the data described
previously to begin to address this issue.
Initial inspection of classical, p53 activated genes indicated
that Ad5 infection induced decreases (for example, CDKN7A
and all cyclin G genes) or no change (for example, BAX and
MDM2) in the concentrations of corresponding RNAs. To
conduct a systematic analysis, we took advantage of a careful
microarray study conducted by Kannan and coworkers [94],
in which they identified a set of primary p53 target genes
using a temperature sensitive p53 protein synthesized in a
p53 null human cancer cell line. This group identified a core
set of primary p53 target genes that exhibited significant
expression changes when cells were shifted to the permissive
temperature, both in the presence and absence of cyclohex-
imide. This approach, which excludes indirect p53 responses
that are likely to be dependent on protein synthesis, identified
approximately 50 genes as primary targets. We therefore iso-
lated these genes in our dataset. We found that the vast
majority of primary p53 target genes exhibited either no
response to Ad5 infection or, most frequently, a reversal of
p53 induced changes (Figure 9). Thus, most genes activated
by p53 were either repressed upon Ad5 infection or
unchanged in expression. On the other hand, genes normally
directly repressed by p53 were de-repressed during adenovi-
rus infection. We therefore conclude that that Ad5
orchestrates an extremely effective suppression of p53 tran-
scriptional activity. These observations provide the first evi-
dence suggesting that the E1B 55 kDa protein counters the
transcriptional function of activated p53 in Ad5 infected cells.
Conclusion
One of the most remarkable conclusions to emerge from the
global analysis of the responses of quiescent fibroblasts to
Ad5 infection presented here is that a small number of viral
gene products can induce massive reprogramming of cellular
gene expression. Even with application of stringent filters,
some 10% of the 20,000 or so human genes examined
increased or decreased in expression specifically in Ad5
infected cells. Our data also indicate that previously described
properties of viral early proteins, such as binding of E1A gene
products to Rb family members, are likely to account for the
responses of particular sets of cellular genes. Nevertheless, in
terms of explanatory power, such well characterized func-
tions of viral proteins represent but the tip of the iceberg, for
they apply to no more than 5% of the changes observed. It is
probable that effects of activities of viral proteins that are not
yet well understood, for example the interaction of CR1 of E1A
proteins with cellular transcriptional co-activators, contrib-
ute to the reprogramming of cellular gene expression. Sec-
ondary consequences of the effects of viral early proteins are
also likely to contribute via induction of transcriptional
cascades.
It is also apparent that a significant fraction of the alterations
in cellular gene expression represent Ad5-induced reversal of
the quiescence program with concomitant induction of the
core serum response, and activation of expression of many
genes associated with cell proliferation. These observations
provide the first experimental support for the long-held view
that the mitogenic activity of adenoviral E1A proteins, which
is crucial for transformation of nonpermissive cells, optimizes
the environment of permissive cells for viral replication.
Clearly, it will be important in future experiments to examine
both cellular responses and progression through the infec-
tious cycle in quiescent fibroblasts infected by viruses carry-
ing mutations that impair specific functions of these viral
early proteins. Such information should facilitate design of
adenoviral vectors for therapeutic applications.
Materials and methods
Cells and virus
Human Ad5 was propagated in HeLa cells in suspension cul-
ture, as described previously [95]; purified by adsorption to
an AdenoPack™ membrane (Sartorius, Goettingen, Ger-
many), in accordance with the manufacturer's instructions;
and titered by plaque assay on HeLa cell monolayers [96].
Primary HFFs were maintained in monolayer culture in Dul-
becco's modified essential medium (GIBCO-BRL, Gaithers-
burg, MD, USA) supplemented with 10% (vol/vol) fetal
bovine serum (Gemini, West Sacramento, CA, USA). Before
Ad5 infection, HFFs were cultured in six-well dishes until 3
days after they had become fully confluent. They were then
infected with 30 plaque forming units/cell of Ad5, a multiplic-
ity previously determined to be sufficient for 100% infection
of HFFs [51], or were mock infected. After adsorption of virusR58.14 Genome Biology 2007,     Volume 8, Issue 4, Article R58       Miller et al. http://genomebiology.com/2007/8/4/R58
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Ad5 induced changes of expression of E2F target genes organized by function Figure 8
Ad5 induced changes of expression of E2F target genes organized by function. E2F target genes, identified by Ren and coworkers [86], were organized by 
cellular function. Genes significantly regulated by Ad5 (those that pass fold change filter applied previously) are indicated with red/UP or green/DOWN. 
Grey indicates genes not significantly regulated by Ad5. (Note that none of the 67 E2F target genes were significantly downregulated.)
MLH1  MutL homolog 1, colon cancer, nonpolyposis type 2  SUPT4H1  Suppressor of Ty 4 homolog 1
CENPE  Centromere protein E, 312kDa  UP HMGB3  High-mobility group box 3 
BUB3  BUB3 budding uninhibited by benzimidazoles 3 homolog MYC  V-myc myelocytomatosis viral oncogene homolog
AURKB  Aurora kinase B  UP SMARCA3  SWI/SNF related regulator of chromatin UP
CDC6  CDC6 cell division cycle 6 homolog  UP PTTG2  **Pituitary tumor-transforming 2  UP
CDK2  Cyclin-dependent kinase 2  UP MCM3  MCM3 minichromosome maintenance deficient 3  UP
MYC  V-myc myelocytomatosis viral oncogene homolog  MCM5  MCM5 minichromosome maintenance deficient 5 UP
CKS1B  CDC28 protein kinase regulatory subunit 1B  UP TEAD4  TEA domain family member 4 
H2AFX  H2A histone family, member X  UP MCM6  MCM6 minichromosome maintenance deficient 6  UP
MCM3  MCM3 minichromosome maintenance deficient UP ZNF267  Zinc finger protein 267 
MCM5  MCM5 minichromosome maintenance deficient 5 UP NFE2L1  Nuclear factor (erythroid-derived 2)-like 1 
MCM6  MCM6 minichromosome maintenance deficient 6 UP CALR  Calreticulin 
MSH2  MutS homolog 2, colon cancer UP
PCNA  Proliferating cell nuclear antigen  UP RPA3  Replication protein A3, 14kDa 
PTTG2  **Pituitary tumor-transforming 2  UP PRKDC  Protein kinase, DNA-activated, catalytic polypeptide  UP
RAD54L  RAD54-like (S. cerevisiae)  UP MLH1  MutL homolog 1, colon cancer, nonpolyposis type 2
SMC2L1  SMC2 structural maintenance of chromosomes 2-like 1  UP PCNA  Proliferating cell nuclear antigen  UP
TOP2A  Topoisomerase (DNA) II alpha 170kDa  UP
CENPA  Centromere protein A, 17kDa  MSH2  MutS homolog 2, colon cancer, nonpolyposis type 1 UP
TRA1  Tumor rejection antigen (gp96) 1  UNG  Uracil-DNA glycosylase  UP
SMARCA3  SWI/SNF related regulator of chromatin UP RAD54L  RAD54-like UP
PKN2  Protein kinase N2  POLD1  DNA Polymerase delta 1, catalytic subunit 125kDa  UP
EIF2B2  Eukaryotic translation initiation factor 2B, subunit 2 beta UP PTTG2  **Pituitary tumor-transforming 2  UP
AURKB  Aurora kinase B  UP FEN1  Flap structure-specific endonuclease 1  UP
H2AFX  H2A histone family, member X  UP H2AFX  H2A histone family, member X  UP
HSPC150  HSPC150 protein similar to ubiquitin-conjugating enzyme  UP
HIST2H2AA  **Histone 2, H2aa  BUB3  BUB3 budding uninhibited by benzimidazoles 3 homolog
CDK2  Cyclin-dependent kinase 2  UP SMC2L1  SMC2 structural maintenance of chromosomes 2-like 1 UP
H2AFZ  H2A histone family, member Z  UP CDK2  Cyclin-dependent kinase 2  UP
VCP  Valosin-containing protein  PTTG2  **Pituitary tumor-transforming 2  UP
PRKDC  Protein kinase, DNA-activated, catalytic polypeptide  UP CDC6  CDC6 cell division cycle 6 homolog  UP
CALR  Calreticulin  H2AFX  H2A histone family, member X  UP
RAD54L  RAD54-like UP
RPA3  Replication protein A3, 14kDa  CENPE  Centromere protein E, 312kDa  UP
MSH2  MutS homolog 2, colon cancer, nonpolyposis type 1 UP
MLH1  MutL homolog 1, colon cancer, nonpolyposis type 2  PIG8  Translokin 
RFC3  Replication factor C (activator 1) 3, 38kDa  UP PPP2R2B protein phosphatase 2, regulatory subunit B
RFC2  Replication factor C (activator 1) 2, 40kDa UP VCP  Valosin-containing protein 
PCNA  Proliferating cell nuclear antigen  UP RABIF  RAB interacting factor  UP
TOP2A  Topoisomerase (DNA) II alpha 170kDa  UP PCNA  Proliferating cell nuclear antigen  UP
MCM3  MCM3 minichromosome maintenance deficient 3 UP TOP2A  Topoisomerase (DNA) II alpha 170kDa  UP
CDK2  Cyclin-dependent kinase 2  UP FEN1  Flap structure-specific endonuclease 1  UP
POLA2  Polymerase (DNA directed), alpha 2 (70kD subunit)  UP PKN2  Protein kinase N2 
POLD1  Polymerase (DNA directed), delta 1, catalytic subunit 125kDa  UP STAM  Signal transducing adaptor molecule 1 
CDC6  CDC6 cell division cycle 6 homolog UP
FEN1  Flap structure-specific endonuclease 1  UP BUB3  BUB3 budding uninhibited by benzimidazoles 3 homolog
MCM6  MCM6 minichromosome maintenance deficient 6  UP PCNA  Proliferating cell nuclear antigen  UP
TK1  Thymidine kinase 1, soluble  UP MYC  V-myc myelocytomatosis viral oncogene homolog 
MCM5  MCM5 minichromosome maintenance deficient 5 UP CDK2  Cyclin-dependent kinase 2  UP
DUT  DUTP pyrophosphatase  UP CDC6  CDC6 cell division cycle 6 homolog (S. cerevisiae)  UP
RRM1  Ribonucleotide reductase M1 polypeptide  UP
PRIM2A  Primase, polypeptide 2A, 58kDa  CENPA  Centromere protein A, 17kDa 
SMARCA3  SWI/SNF related regulator of chromatin UP
PLSCR1  Phospholipid scramblase 1  H2AFZ  H2A histone family, member Z  UP
TRA1  Tumor rejection antigen (gp96) 1  H2AFX  H2A histone family, member X  UP
FEN1  Flap structure-specific endonuclease 1  UP HIST2H2AA  **Histone 2, H2aa 
MLH1  MutL homolog 1, colon cancer, nonpolyposis type 2
POLD1  DNA Polymerase delta 1, catalytic subunit 125kDa  UP PIG8  Translokin 
PTTG2  **Pituitary tumor-transforming 2  UP STAM  Signal transducing adaptor molecule 1 
H2AFX  H2A histone family, member X  UP CALR  Calreticulin 
RAD54L  RAD54-like (S. cerevisiae)  UP VCP  Valosin-containing protein 
PCNA  Proliferating cell nuclear antigen  UP CENPE  Centromere protein E, 312kDa  UP
TOP2A  Topoisomerase (DNA) II alpha 170kDa  UP KIF4A  Kinesin family member 4A 
MSH2  MutS homolog 2, colon cancer, nonpolyposis type 1 UP
UNG  Uracil-DNA glycosylase  UP HMGB3  High-mobility group box 3 
RPA3  Replication protein A3, 14kDa  ZNF267  Zinc finger protein 267 
PRKDC  Protein kinase, DNA-activated, catalytic polypeptide  UP NFE2L1  Nuclear factor (erythroid-derived 2)-like 1 
NFE2L1  Nuclear factor (erythroid-derived 2)-like 1  TEAD4  TEA domain family member 4 
VCP  Valosin-containing protein 
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DNA replication
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Transcription
DNA repair
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for 1 hour at 37°C, the innoculum was removed and replaced
with the original, conditioned medium. Mock and Ad5
infected cells were incubated at 37°C.
Analysis of viral DNA and protein synthesis
Infected cells were scraped from individual wells of six-well
dishes after various periods of infection, washed twice in ice
cold phosphate-buffered saline, and divided into two equal
portions. Total DNA was purified from one portion and the
quantity of viral DNA examined by using 12 cycles of PCR
amplification of a segment of the viral E1A gene, as described
previously [51]. The amplified DNA was analyzed by electro-
phoresis in a 1.4% (weight/vol) agarose gel cast and run in
0.04 M Tris-acetate (pH 7.5) containing 1 mM EDTA. A total
protein lysate was prepared from the second portion of each
sample of cells, as described previously [97]. The viral early
E2 single-stranded DNA-binding protein and late protein V
were detected by immunoblotting with monoclonal antibod-
ies B6 [98] and F58#1 [99], respectively, as described previ-
ously [51].
Analysis of cellular gene expression
Ad5 infected and mock infected HFF cells were harvested for
RNA isolation using the RNeasy Micro™ kit (Invitrogen,
Carlsbad, CA, USA), following the manufacturer's instruc-
tions. In brief, medium was completely removed from wells
followed by immediate addition of a denaturing lysis buffer
(RLT™, supplied by the manufacturer), homogenization by
vortexing, and freezing on dry ice. All samples were thawed
and processed for RNA isolation in parallel. The purification
included an on-column DNAse I digestion step. The yield and
quality of each RNA sample were assessed by nano-drop
spectrophotometry and agarose gel electrophoresis, respec-
tively. For each sample, 400 ng RNA was linearly amplified
and labeled in the presence of Cy5-CTP, using Low RNA Input
Linear Amplification reagents (Agilent Technologies, Santa
Clara, CA, USA). Amplified RNA was purified on RNAeasy™
spin columns (Qiagen, Valencia, CA, USA). A mixture of total
cellular RNA from five different types of human cells, includ-
ing both transformed cell lines and primary cells, was labeled
with Cy3-CTP and purified in the same way for use as a com-
mon reference. The amplification/labeling reactions yielded
specific activities of 10 to 12 pmol Cy3/Cy5 per μg cRNA.
Samples were processed and hybridized to Agilent Whole
Human 44 k DNA microarrays for 17 hours at 60°C in parallel
staggered batches using the Agilent hybridization kit. Slides
were washed in parallel according to the manufacturer's pro-
tocol, which included a final drying rinse in acetonitrile, and
scanned in batch using an Agilent two color scanner. All pre-
and post-hybridization procedures with labeled cRNAs were
performed in an ozone free facility.
Data normalization and processing
Raw image data were extracted using Agilent Feature extrac-
tion software with the protocol settings recommended by the
manufacturer. Raw channel intensities were adjusted for
Changes in expression of direct p53 target genes induced by Ad5 infection Figure 9
Changes in expression of direct p53 target genes induced by Ad5 infection. 
The 50 or so genes that are direct p53 targets in human lung fibroblasts 
[94] are shown clustered based on the changes in their expression 
observed in adenovirus type 5 (Ad5) infected human foreskin fibroblasts. 
The column labeled p53 summarizes the p53 induced alterations in 
expression of these genes, which are listed at the right. Ramps above 
panels indicate increases in time after infection.
CDKN1A 
ENG 
FOSL2 
MGC5370 
PURA 
SMAD7 
EXT2 
MAN2B1 
LCAT 
KIAA0247 
SURF1 
PMP22 
HAN11 
CTDSP2 
TST 
LOXL1 
ADFP 
IGFBP6 
NINJ1 
DDB2 
CES2 
APBA2 
NDN 
PRKAB1 
APLP1 
NEFL 
SMTN 
GTF2H2 
PCNA 
PPAT 
CCNE1 
SLC19A1 
CDC6 
SCRIB 
EIF4A1 
INA 
HRAS 
POMZP3 
COL18A1 
DMWD 
BBC3 
PDLIM4 
Ad5 Mock
p53 0 0R58.16 Genome Biology 2007,     Volume 8, Issue 4, Article R58       Miller et al. http://genomebiology.com/2007/8/4/R58
Genome Biology 2007, 8:R58
background using a spatial de-trend algorithm, dye normali-
zation was performed using an intensity-dependent lowness
normalization based on spots that passed a rank consistency
filter, and final spot values were computed as the log2 of proc-
essed channel intensity ratios (red/green). The extracted data
were loaded onto the Princeton University PUMA database
[52] for storage and spot quality filtering. Spots flagged by the
extraction software as feature uniformity outliers, in either
channel, were culled. In addition, only spots flagged as well
above background were included in the analysis; uncorrected
channel intensity values passed a two sided t-test (P = 0.01)
for significance, and background-corrected signals were
greater than 2.6 times the standard deviation of global back-
ground. Processing of corrected and filtered log2 dye ratio
data, including dataset manipulations, zero transformation,
filtering, and visualization, were performed using the follow-
ing freeware: PCL-Analysis (Gavin Scherlock, Stanford Uni-
versity, Palo Alto, CA, USA), TIGR MeV data analysis
package, and Java-Treeview (Alok Jerome Saldanha, Stan-
ford University, Palo Alto, CA, USA). Primary probe acces-
sions supplied by Agilent Technologies were mapped to
Unigene clusters via batch retrieval using SOURCE [100]
using the Protein Information Resource batch retrieval utility
[101]. To establish a dataset of unique genes, the expression
values associated with multiple probes referencing the same
gene were averaged.
RT-PCR analysis
Cellular RNA (100 ng) isolated from HFF cells at 0, 18, 24, 30,
40 and 54 hours after infection (as described in a previous
section) was analyzed by RT-PCR for several human genes
using the RT-PCR Master Mix (2 ×) kit (USB, Cleveland, OH,
USA) in the presence of 3 μCi/reaction [α32P]-dATP (3000
Ci/mmol; Perkin Elmer, Waltham, MA, USA). For each gene,
the optimal number of cycles was experimentally determined
to ensure exponential amplification. The primer pairs, rang-
ing in size from 19 to 24 bases, were designed to amplify
G M N N  ( p o s i t i o n s  + 6 8  t o  + 3 4 7  o f  t h e  c o d i n g  s e q u e n c e ) ,
CCNE1 (+79 to +314), E2F2 (+1,133 to +1,344), MSH2 (+807
to +1,053), SFRP1 (+1,366 to +1,609), FAM45A (+606 to
+759), NOLC1 (+639 to +886), LENG9 (+448 to +631),
IGFBP5 (+1,208 to +1,445), EIF4EBP2 (+564 to +720),
MAP3K3 (+841 to +1,022), PNKP (+519 to +728), RAB31
(+315 to +560), RHOQ (+445 to +601), NEUROG1 (+228 to
+379), and CDC6 (+1472 to +1981). The RT-PCR products,
ranging in size from about 150 to about 510 base pairs, were
resolved by electrophoresis in 6% acrylamide gels, cast, and
run in 0.25 × TBE (0.0225 mol/l Tris-borate [pH 7.5], 0.5
mmol/l EDTA). Signals were quantified by using a Molecular
Dynamics STORM 869 Phosphor Imaging Scanner and
Image Quant™ TL software (Amersham Biosciences, Piscata-
way, NJ, USA).
Consensus clustering
Several clustering algorithms, including k-means used here,
are sensitive to random initialization. To ensure our cluster-
ing result was consistent across different initializations and
generally robust, we used consensus clustering [102]. We
applied consensus clustering to our data by performing 5,000
iterations of k-means clustering, each with a different,
random initialization. We used Pearson correlation as the dis-
tance metric with k = 8 (see figure of merit [FOM] discussion,
below). For every possible pair of genes, we counted the
number of cluster results in which that pair was co-clustered.
The final step was to derive a consensus clustering result from
the average behavior over the entire set of iterations. We
applied the average-linkage agglomerative approach,
described by Monit and coworkers [102], which uses the frac-
tion of iterations in which each pair of genes co-clustered as a
similarity metric and builds a hierarchical linkage tree
accordingly. Based on FOM analysis (described below), we
picked a similarity threshold that resulted in eight total
clusters.
One requirement of the k-means algorithm, which is the basis
of our consensus clustering, is that a total number of clusters,
k, must be chosen in advance. A common approach to
automatically determining k is to use FOM analysis, which
attempts to ascertain the minimal number of clusters neces-
sary to produce a good fit of the data to the cluster centroids.
Specifically, the FOM for a particular choice of clustering
parameters (for instance, the number of clusters) is computed
by iteratively withholding a single condition from each
expression vector, clustering the data, and measuring how
predictive cluster centroids are of all member genes' held-out
expression measurement [60]. We used the FOM utility in the
MeV Tiger toolbox [103] to perform this analysis and deter-
mined that the FOM reached a minimum for k = 8. All figures
illustrating clustering results can be interactively viewed on
our supplemental website [104] (clustered data can also be
downloaded for viewing with Java-Treeview [105]).
Gene Ontology enrichment analysis
G e n e  O n t o l o g y  ( G O )  a n a l y s e s  w e r e  p e r f o r m e d  i n  M a t l a b
using a script written by CLM and DLM based on GO Ter-
mFinder [106]. Updated gene association and ontology files
were downloaded from the GO Consortium database [61] on
24 January 2007, and parsed to create a Matlab reference
object for the process ontology. These were used to map Uni-
prot identifiers to their GO process identifiers. The hypergeo-
metric distribution was used to calculate the significance of
GO term assignments in gene clusters. The background set of
genes was the set of genes represented on the array, and the P
values are Bonferroni corrected for multiple hypothesis test-
ing. The Matlab scripts and supporting data can be down-
loaded from our supplementary website [104]. GO term
results were validated and visualized using GOLEM, an inter-
active tool for browsing the GO [107].http://genomebiology.com/2007/8/4/R58 Genome Biology 2007,     Volume 8, Issue 4, Article R58       Miller et al. R58.17
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Additional data files
The following additional data are available with the online
version of this paper. Additional file 1 provides dataset shown
in Figure 3 (k-means clustered expression data for all genes
that pass the fold change and specificity filters). Additional
data file 2 shows the validation of microarray data by RT-
PCR.
Additional data file 1 Dataset shown in Figure 3 Provided is the dataset shown in Figure 3 (k-means clustered  expression data for all genes that pass the fold change and specifi- city filters). Click here for file Additional data file 2 Validation of microarray data Shown is the validation of microarray data by RT-PCR. Click here for file
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